Search:
Sunday, Jul-12 2020 16:41 WIB
  • AGRI 1,053.810 -9.890 (-0.930%)
  • BASIC-IND 760.580 -2.700 (-0.354%)
  • BISNIS-27 450.460 -1.910 (-0.422%)
  • COMPOSITE 5,031.260 -21.530 (-0.426%)
  • CONSUMER 1,799.020 -18.280 (-1.006%)
  • DBX 909.260 -4.690 (-0.513%)
  • FINANCE 1,112.210 1.610 (0.145%)
  • I-GRADE 138.450 -0.180 (-0.130%)
  • IDX30 427.730 -2.700 (-0.627%)
  • IDX80 110.710 -0.910 (-0.815%)
  • IDXBUMN20 286.570 -2.970 (-1.026%)
  • IDXG30 118.360 -0.560 (-0.471%)
  • IDXHIDIV20 381.210 -2.970 (-0.773%)
  • IDXSMC-COM 206.530 -1.130 (-0.544%)
  • IDXSMC-LIQ 242.710 -2.590 (-1.056%)
  • IDXV30 100.070 -1.360 (-1.341%)
  • INFOBANK15 815.690 2.640 (0.325%)
  • INFRASTRUC 893.850 -4.990 (-0.555%)
  • Investor33 371.860 -1.660 (-0.444%)
  • ISSI 146.550 -1.170 (-0.792%)
  • JII 544.500 -5.170 (-0.941%)
  • JII70 181.220 -1.850 (-1.011%)
  • KOMPAS100 1,007.730 -4.530 (-0.448%)
  • LQ45 784.560 -4.970 (-0.629%)
  • MANUFACTUR 1,194.160 -9.830 (-0.816%)
  • MBX 1,401.040 -5.830 (-0.414%)
  • MINING 1,284.560 -7.050 (-0.546%)
  • MISC-IND 872.400 -10.020 (-1.136%)
  • MNC36 285.480 -1.260 (-0.439%)
  • PEFINDO25 254.370 0.530 (0.209%)
  • PROPERTY 316.060 -3.800 (-1.188%)
  • SMinfra18 244.360 -2.710 (-1.097%)
  • SRI-KEHATI 316.000 -1.050 (-0.331%)
  • TOTAL_MARKET 5,031.260 -21.530 (-0.426%)
  • TRADE 603.260 -3.290 (-0.542%)
  • © 2010 IMQ - LKBN ANTARA
  • AALI 8,475 -200 (-2.31%)
  • ABBA 50 0 (0.00%)
  • ABMM 1,250 -75 (-5.66%)
  • ACES 1,555 -5 (-0.32%)
  • ACST 268 2 (0.75%)
  • ADES 855 0 (0.00%)
  • ADHI 635 -5 (-0.78%)
  • ADMF 7,300 25 (0.34%)
  • ADMG 103 1 (0.98%)
  • ADRO 1,085 -10 (-0.91%)
  • AGAR 515 -35 (-6.36%)
  • AGII 560 -20 (-3.45%)
  • AGRO 150 7 (4.90%)
  • AGRS 100 -2 (-1.96%)
  • AKKU 50 0 (0.00%)
  • AKRA 2,420 -60 (-2.42%)
  • AKSI 314 -22 (-6.55%)
  • ALDO 400 0 (0.00%)
  • ALMI 210 6 (2.94%)
  • ALTO 330 -24 (-6.78%)
  • AMAG 280 10 (3.70%)
  • AMAN 196 1 (0.51%)
  • AMAR 392 2 (0.51%)
  • AMFG 2,750 150 (5.77%)
  • AMIN 270 2 (0.75%) © 2010 IMQ - LKBN ANTARA
  • AMOR 1,975 -25 (-1.25%)
  • AMRT 780 -5 (-0.64%)
  • ANDI 50 0 (0.00%)
  • ANJT 555 -10 (-1.77%)
  • ANTM 645 -5 (-0.77%)
  • APEX 175 -6 (-3.31%)
  • APIC 825 -20 (-2.37%)
  • APII 206 -14 (-6.36%)
  • APLI 124 14 (12.73%)
  • APLN 112 -1 (-0.88%)
  • ARGO 1,280 255 (24.88%)
  • ARII 520 -10 (-1.89%)
  • ARNA 368 -2 (-0.54%)
  • ARTA 324 -24 (-6.90%)
  • ARTO 2,960 10 (0.34%)
  • ASDM 970 0 (0.00%)
  • ASGR 665 -5 (-0.75%)
  • ASII 4,830 -70 (-1.43%)
  • ASJT 125 -5 (-3.85%)
  • ASMI 1,210 -10 (-0.82%)
  • ASPI 322 8 (2.55%)
  • ASPI-W 39 0 (0.00%)
  • ASRI 130 -1 (-0.76%)
  • ASSA 440 0 (0.00%)
  • ATIC 665 -45 (-6.34%) © 2010 IMQ - LKBN ANTARA
  • AUTO 910 5 (0.55%)
  • AYLS 50 0 (0.00%)
  • AYLS-W 4 0 (0.00%)
  • BABP-W4 9 1 (12.50%)
  • BACA 380 2 (0.53%)
  • BAJA 60 -3 (-4.76%)
  • BALI 890 0 (0.00%)
  • BAPI 50 0 (0.00%)
  • BAPI-W 3 1 (50.00%)
  • BATA 545 -5 (-0.91%)
  • BAYU 1,000 -45 (-4.31%)
  • BBCA 31,000 500 (1.64%)
  • BBHI 138 -10 (-6.76%)
  • BBKP 183 0 (0.00%)
  • BBMD 1,470 -25 (-1.67%)
  • BBNI 4,670 -60 (-1.27%)
  • BBRI 3,110 -30 (-0.96%)
  • BBSS 145 0 (0.00%)
  • BBSS-W 4 0 (0.00%)
  • BBTN 1,295 -20 (-1.52%)
  • BBYB 290 8 (2.84%)
  • BCAP 159 1 (0.63%)
  • BCIP 50 0 (0.00%)
  • BDMN 2,800 -20 (-0.71%)
  • BEEF 226 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • BEEF-W 16 1 (6.67%)
  • BEKS 50 0 (0.00%)
  • BELL 685 -15 (-2.14%)
  • BESS 236 -10 (-4.07%)
  • BEST 117 -4 (-3.31%)
  • BFIN 280 8 (2.94%)
  • BGTG 52 -3 (-5.45%)
  • BHAT 432 -8 (-1.82%)
  • BHIT 50 0 (0.00%)
  • BIKA 172 2 (1.18%)
  • BIMA 50 0 (0.00%)
  • BINA 870 0 (0.00%)
  • BIPI 50 0 (0.00%)
  • BIPI-W 8 0 (0.00%)
  • BIPP 57 -3 (-5.00%)
  • BIRD 1,020 -45 (-4.23%)
  • BISI 800 -20 (-2.44%)
  • BJBR 880 -10 (-1.12%)
  • BJTM 545 0 (0.00%)
  • BKDP 50 0 (0.00%)
  • BKSL 50 0 (0.00%)
  • BKSW 72 -3 (-4.00%)
  • BLTA 50 0 (0.00%)
  • BLUE 494 -4 (-0.80%)
  • BMAS 320 14 (4.58%) © 2010 IMQ - LKBN ANTARA
  • BMRI 5,175 -75 (-1.43%)
  • BMSR 53 -3 (-5.36%)
  • BMTR 188 -3 (-1.57%)
  • BNBA 290 -4 (-1.36%)
  • BNBR 50 0 (0.00%)
  • BNGA 830 75 (9.93%)
  • BNII 161 -2 (-1.23%)
  • BNLI 1,285 0 (0.00%)
  • BOGA 1,370 -5 (-0.36%)
  • BOLA 160 0 (0.00%)
  • BOSS 80 -1 (-1.23%)
  • BPTR 80 2 (2.56%)
  • BRAM 5,325 -375 (-6.58%)
  • BRIS 474 36 (8.22%)
  • BRMS 50 0 (0.00%)
  • BRPT 1,220 -5 (-0.41%)
  • BRPT-W 770 40 (5.48%)
  • BSDE 745 -20 (-2.61%)
  • BSIM 520 10 (1.96%)
  • BSIM-W3 20 0 (0.00%)
  • BTEK 50 0 (0.00%)
  • BTON 192 1 (0.52%)
  • BTPN 2,160 -30 (-1.37%)
  • BTPS 3,200 -20 (-0.62%)
  • BUDI 84 -3 (-3.45%) © 2010 IMQ - LKBN ANTARA
  • BUKK 680 -50 (-6.85%)
  • BULL 326 22 (7.24%)
  • BULL-W2 107 18 (20.22%)
  • BUMI 50 0 (0.00%)
  • BUVA 56 0 (0.00%)
  • BVIC 69 0 (0.00%)
  • BWPT 90 -1 (-1.10%)
  • BYAN 12,875 475 (3.83%)
  • CAKK 50 0 (0.00%)
  • CAKK-W 9 0 (0.00%)
  • CAMP 210 4 (1.94%)
  • CANI 161 -12 (-6.94%)
  • CARE 314 -6 (-1.88%)
  • CARS 50 0 (0.00%)
  • CASA 378 0 (0.00%)
  • CASH 535 0 (0.00%)
  • CASH-W 22 0 (0.00%)
  • CASS 193 2 (1.05%)
  • CBMF 200 -4 (-1.96%)
  • CCSI 250 4 (1.63%)
  • CEKA 1,960 5 (0.26%)
  • CENT 89 0 (0.00%)
  • CFIN 193 -1 (-0.52%)
  • CINT 248 -4 (-1.59%)
  • CITA 1,760 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • CITY 50 0 (0.00%)
  • CITY-W 13 1 (8.33%)
  • CLAY 1,990 180 (9.94%)
  • CLEO 468 4 (0.86%)
  • CLPI 715 0 (0.00%)
  • CMNP 1,270 60 (4.96%)
  • CNKO 50 0 (0.00%)
  • COCO 840 30 (3.70%)
  • CPIN 6,000 -50 (-0.83%)
  • CPRI-W 14 0 (0.00%)
  • CPRO 50 0 (0.00%)
  • CSIS 50 0 (0.00%)
  • CSMI 228 -12 (-5.00%)
  • CSRA 228 -2 (-0.87%)
  • CTRA 650 -25 (-3.70%)
  • DADA 92 -6 (-6.12%)
  • DADA-W 4 0 (0.00%)
  • DEAL 91 1 (1.11%)
  • DEFI 1,790 -10 (-0.56%)
  • DGIK 50 0 (0.00%)
  • DILD 182 -1 (-0.55%)
  • DIVA 1,680 30 (1.82%)
  • DKFT 106 0 (0.00%)
  • DLTA 4,900 20 (0.41%)
  • DMAS 179 -2 (-1.10%) © 2010 IMQ - LKBN ANTARA
  • DMMX 186 -7 (-3.63%)
  • DMND 950 0 (0.00%)
  • DNAR 254 0 (0.00%)
  • DNET 3,280 10 (0.31%)
  • DOID 157 -1 (-0.63%)
  • DPNS 274 14 (5.38%)
  • DPUM 77 -2 (-2.53%)
  • DSFI 68 0 (0.00%)
  • DSNG 336 -4 (-1.18%)
  • DSSA 21,250 -625 (-2.86%)
  • DUCK 446 -2 (-0.45%)
  • DUTI 4,380 -300 (-6.41%)
  • DVLA 2,250 -10 (-0.44%)
  • DWGL 248 0 (0.00%)
  • DWGL-W 52 2 (4.00%)
  • DYAN 51 1 (2.00%)
  • EAST 60 1 (1.69%)
  • EAST-W 6 0 (0.00%)
  • EKAD 1,080 -15 (-1.37%)
  • ELSA 242 2 (0.83%)
  • ELTY 50 0 (0.00%)
  • EMTK 4,500 -60 (-1.32%)
  • ENRG 52 -1 (-1.89%)
  • ENVY 133 7 (5.56%)
  • EPAC 294 26 (9.70%) © 2010 IMQ - LKBN ANTARA
  • ERAA 1,315 15 (1.15%)
  • ERTX 127 -3 (-2.31%)
  • ESIP 199 -11 (-5.24%)
  • ESIP-W 11 -1 (-8.33%)
  • ESSA 156 -1 (-0.64%)
  • ESTA 99 2 (2.06%)
  • ESTI 50 0 (0.00%)
  • EXCL 2,860 -60 (-2.05%)
  • FAST 935 0 (0.00%)
  • FILM 179 -5 (-2.72%)
  • FIRE 105 -3 (-2.78%)
  • FITT 71 18 (33.96%)
  • FITT-W 29 15 (107.14%)
  • FOOD 131 12 (10.08%)
  • FORZ 50 0 (0.00%)
  • FPNI 90 -4 (-4.26%)
  • FREN 97 -1 (-1.02%)
  • FREN-W 24 0 (0.00%)
  • FUJI 106 -1 (-0.93%)
  • GAMA 50 0 (0.00%)
  • GDST 60 -1 (-1.64%)
  • GDYR 1,375 -25 (-1.79%)
  • GEMA 366 -2 (-0.54%)
  • GGRM 46,875 -350 (-0.74%)
  • GGRP 262 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • GHON 1,535 -115 (-6.97%)
  • GIAA 258 -8 (-3.01%)
  • GJTL 402 12 (3.08%)
  • GLOB 174 -1 (-0.57%)
  • GLVA 326 -2 (-0.61%)
  • GMFI 84 0 (0.00%)
  • GOLD 194 -2 (-1.02%)
  • GOOD 1,300 0 (0.00%)
  • GPRA 51 -1 (-1.92%)
  • GSMF 113 4 (3.67%)
  • GTBO 81 -2 (-2.41%)
  • GWSA 96 0 (0.00%)
  • GZCO 50 0 (0.00%)
  • HDFA 160 3 (1.91%)
  • HDIT 448 -10 (-2.18%)
  • HEAL 2,960 -40 (-1.33%)
  • HELI 238 2 (0.85%)
  • HELI-W 8 0 (0.00%)
  • HERO 875 0 (0.00%)
  • HEXA 3,500 0 (0.00%)
  • HITS 630 0 (0.00%)
  • HKMU 82 -1 (-1.20%)
  • HMSP 1,650 -15 (-0.90%)
  • HOKI 650 0 (0.00%)
  • HOTL 50 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • HRME 78 -3 (-3.70%)
  • HRTA 228 0 (0.00%)
  • HRUM 1,190 -30 (-2.46%)
  • IATA 50 0 (0.00%)
  • IBFN-W 6 1 (20.00%)
  • ICBP 9,225 -125 (-1.34%)
  • ICON 57 -2 (-3.39%)
  • IDPR 170 5 (3.03%)
  • IFII 134 -1 (-0.74%)
  • IFSH 440 30 (7.32%)
  • IGAR 260 0 (0.00%)
  • IKAN 570 40 (7.55%)
  • IKBI 224 -8 (-3.45%)
  • IMAS 630 -15 (-2.33%)
  • IMJS 246 0 (0.00%)
  • IMPC 1,265 0 (0.00%)
  • INAF 1,020 -35 (-3.32%)
  • INAI 362 18 (5.23%)
  • INCI 496 -29 (-5.52%)
  • INCO 3,090 -10 (-0.32%)
  • INDF 6,500 -50 (-0.76%)
  • INDO 118 8 (7.27%)
  • INDO-W 31 -2 (-6.06%)
  • INDR 2,300 40 (1.77%)
  • INDS 2,170 50 (2.36%) © 2010 IMQ - LKBN ANTARA
  • INDY 745 -10 (-1.32%)
  • INKP 7,775 -50 (-0.64%)
  • INOV 248 -2 (-0.80%)
  • INPC 51 -1 (-1.92%)
  • INPC-W 4 0 (0.00%)
  • INPP 700 0 (0.00%)
  • INPS 1,630 -30 (-1.81%)
  • INTD 149 0 (0.00%)
  • INTP 11,600 -125 (-1.07%)
  • IPCC 430 -4 (-0.92%)
  • IPCM 198 -2 (-1.00%)
  • IPOL 74 1 (1.37%)
  • IPTV 358 0 (0.00%)
  • IPTV-W 79 2 (2.60%)
  • IRRA 575 -5 (-0.86%)
  • ISAT 2,560 -10 (-0.39%)
  • ISSP 128 -5 (-3.76%)
  • ITIC 1,100 30 (2.80%)
  • ITMG 7,450 -250 (-3.25%)
  • JAST 98 -1 (-1.01%)
  • JAYA 90 1 (1.12%)
  • JAYA-W 13 -1 (-7.14%)
  • JECC 6,800 -100 (-1.45%)
  • JGLE 50 0 (0.00%)
  • JKON 372 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • JMAS 216 -4 (-1.82%)
  • JPFA 1,150 -30 (-2.54%)
  • JRPT 412 -2 (-0.48%)
  • JSKY 81 -1 (-1.22%)
  • JSMR 4,410 -20 (-0.45%)
  • JTPE 770 0 (0.00%)
  • KAEF 1,200 -10 (-0.83%)
  • KAYU 50 0 (0.00%)
  • KBAG 398 2 (0.51%)
  • KBAG-W 90 2 (2.27%)
  • KBLI 468 60 (14.71%)
  • KBLM 224 -2 (-0.88%)
  • KBLV 346 -10 (-2.81%)
  • KDSI 910 0 (0.00%)
  • KEEN 308 -22 (-6.67%)
  • KEJU 965 10 (1.05%)
  • KICI 218 -4 (-1.80%)
  • KIJA 145 4 (2.84%)
  • KINO 3,300 -30 (-0.90%)
  • KIOS-W 36 1 (2.86%)
  • KKGI 206 6 (3.00%)
  • KLBF 1,470 -60 (-3.92%)
  • KMTR 238 0 (0.00%)
  • KOBX 91 1 (1.11%)
  • KONI 432 -18 (-4.00%) © 2010 IMQ - LKBN ANTARA
  • KOPI 500 0 (0.00%)
  • KOTA 620 -20 (-3.12%)
  • KOTA-W 362 2 (0.56%)
  • KPAL 68 -2 (-2.86%)
  • KPAS 50 0 (0.00%)
  • KPAS-W 9 1 (12.50%)
  • KPIG 111 1 (0.91%)
  • KRAS 350 4 (1.16%)
  • KREN 137 -2 (-1.44%)
  • LAND 230 -4 (-1.71%)
  • LCKM 328 -24 (-6.82%)
  • LEAD 50 0 (0.00%)
  • LIFE 7,500 300 (4.17%)
  • LINK 2,050 -50 (-2.38%)
  • LION 376 -12 (-3.09%)
  • LMAS 51 -2 (-3.77%)
  • LMPI 77 -3 (-3.75%)
  • LMSH 308 28 (10.00%)
  • LPCK 810 -45 (-5.26%)
  • LPIN 270 44 (19.47%)
  • LPKR 158 -2 (-1.25%)
  • LPPF 1,380 -45 (-3.16%)
  • LPPS 92 13 (16.46%)
  • LRNA 138 0 (0.00%)
  • LSIP 845 -25 (-2.87%) © 2010 IMQ - LKBN ANTARA
  • LTLS 440 0 (0.00%)
  • LUCK 314 2 (0.64%)
  • MAIN 605 5 (0.83%)
  • MAMI 50 0 (0.00%)
  • MAMI-W 5 0 (0.00%)
  • MAPA 2,450 -60 (-2.39%)
  • MAPB 1,500 5 (0.33%)
  • MAPI 715 -5 (-0.69%)
  • MARI 58 -2 (-3.33%)
  • MARK 805 85 (11.81%)
  • MASA 540 -20 (-3.57%)
  • MBAP 1,685 5 (0.30%)
  • MBSS 334 -2 (-0.60%)
  • MBTO 65 0 (0.00%)
  • MCAS 1,860 35 (1.92%)
  • MCOR 153 4 (2.68%)
  • MDIA 50 0 (0.00%)
  • MDKA 1,485 -50 (-3.26%)
  • MDKI 145 1 (0.69%)
  • MEDC 460 -6 (-1.29%)
  • MEDC-W 27 0 (0.00%)
  • MEGA 6,275 0 (0.00%)
  • MERK 2,970 40 (1.37%)
  • META 108 -3 (-2.70%)
  • MFIN 1,020 -30 (-2.86%) © 2010 IMQ - LKBN ANTARA
  • MFMI 510 10 (2.00%)
  • MGRO 680 5 (0.74%)
  • MICE 310 0 (0.00%)
  • MIKA 2,370 30 (1.28%)
  • MINA 50 0 (0.00%)
  • MIRA 50 0 (0.00%)
  • MLBI 10,000 0 (0.00%)
  • MLIA 560 10 (1.82%)
  • MLPL 52 0 (0.00%)
  • MLPT 600 20 (3.45%)
  • MMLP 184 -5 (-2.65%)
  • MNCN 905 -5 (-0.55%)
  • MPMX 486 -2 (-0.41%)
  • MPOW 54 -1 (-1.82%)
  • MPPA 111 0 (0.00%)
  • MPRO 790 -45 (-5.39%)
  • MRAT 130 0 (0.00%)
  • MREI 5,075 -375 (-6.88%)
  • MSIN 250 -10 (-3.85%)
  • MTDL 1,410 5 (0.36%)
  • MTFN 50 0 (0.00%)
  • MTLA 400 0 (0.00%)
  • MTPS 140 0 (0.00%)
  • MTSM 220 0 (0.00%)
  • MTWI 50 -1 (-1.96%) © 2010 IMQ - LKBN ANTARA
  • MYOH 1,015 -10 (-0.98%)
  • MYOR 2,190 -50 (-2.23%)
  • MYTX 53 0 (0.00%)
  • NASA 120 -9 (-6.98%)
  • NATO 302 6 (2.03%)
  • NELY 127 -6 (-4.51%)
  • NFCX 1,750 80 (4.79%)
  • NIKL 492 -13 (-2.57%)
  • NISP 730 5 (0.69%)
  • NOBU 730 -35 (-4.58%)
  • NRCA 358 0 (0.00%)
  • NUSA 50 0 (0.00%)
  • NZIA 199 4 (2.05%)
  • NZIA-W 6 1 (20.00%)
  • OKAS 81 -1 (-1.22%)
  • OPMS 116 -4 (-3.33%)
  • PADI 50 0 (0.00%)
  • PALM 195 0 (0.00%)
  • PAMG 84 -1 (-1.18%)
  • PANI 61 0 (0.00%)
  • PANR 90 1 (1.12%)
  • PANS 865 -65 (-6.99%)
  • PBID 850 -5 (-0.58%)
  • PBRX 252 -4 (-1.56%)
  • PEGE 124 15 (13.76%) © 2010 IMQ - LKBN ANTARA
  • PEHA 1,140 -40 (-3.39%)
  • PGAS 1,135 -25 (-2.16%)
  • PGJO 72 -5 (-6.49%)
  • PGUN 324 64 (24.62%)
  • PICO 198 -6 (-2.94%)
  • PJAA 535 -5 (-0.93%)
  • PKPK 50 0 (0.00%)
  • PLIN 2,370 10 (0.42%)
  • PMJS 126 1 (0.80%)
  • PNBN 815 15 (1.88%)
  • PNBS 50 0 (0.00%)
  • PNIN 730 10 (1.39%)
  • PNLF 180 -1 (-0.55%)
  • POLA 51 -3 (-5.56%)
  • POLL 5,400 25 (0.47%)
  • POLU 910 0 (0.00%)
  • POSA 50 0 (0.00%)
  • POSA-W 3 1 (50.00%)
  • POWR 595 -5 (-0.83%)
  • PPRE 196 -2 (-1.01%)
  • PPRO 50 0 (0.00%)
  • PRAS 114 0 (0.00%)
  • PRDA 3,200 -140 (-4.19%)
  • PRIM 320 42 (15.11%)
  • PRIM-W 5 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • PSAB 180 -7 (-3.74%)
  • PSGO 108 2 (1.89%)
  • PSKT 50 0 (0.00%)
  • PSSI 169 -11 (-6.11%)
  • PTBA 2,070 -30 (-1.43%)
  • PTPP 985 -10 (-1.01%)
  • PTPW 1,120 45 (4.19%)
  • PTRO 1,460 -5 (-0.34%)
  • PTSN 190 1 (0.53%)
  • PURA 123 -9 (-6.82%)
  • PURA-W 12 0 (0.00%)
  • PURE 113 1 (0.89%)
  • PURE-W 12 0 (0.00%)
  • PWON 406 -10 (-2.40%)
  • PYFA 610 -20 (-3.17%)
  • PZZA 690 5 (0.73%)
  • R-LQ45X 835 -10 (-1.18%)
  • RAJA 109 -1 (-0.91%)
  • RALS 560 -10 (-1.75%)
  • RANC 416 -4 (-0.95%)
  • RDTX 4,950 0 (0.00%)
  • REAL 51 -1 (-1.92%)
  • REAL-W 6 0 (0.00%)
  • RICY 95 0 (0.00%)
  • RIGS 206 -10 (-4.63%) © 2010 IMQ - LKBN ANTARA
  • RISE 486 4 (0.83%)
  • RMBA 236 0 (0.00%)
  • RODA 50 0 (0.00%)
  • RONY 161 -12 (-6.94%)
  • ROTI 1,230 15 (1.23%)
  • RUIS 162 -6 (-3.57%)
  • SAFE 191 2 (1.06%)
  • SAME 74 -2 (-2.63%)
  • SAMF 372 -8 (-2.11%)
  • SBAT 104 3 (2.97%)
  • SBAT-W 6 0 (0.00%)
  • SCCO 9,350 25 (0.27%)
  • SCMA 1,235 10 (0.82%)
  • SDMU 50 0 (0.00%)
  • SDPC 112 2 (1.82%)
  • SDRA 755 0 (0.00%)
  • SGRO 1,990 -10 (-0.50%)
  • SHIP 600 0 (0.00%)
  • SIDO 1,225 -5 (-0.41%)
  • SILO 5,075 -50 (-0.98%)
  • SIMP 268 -6 (-2.19%)
  • SINI 575 15 (2.68%)
  • SIPD 1,085 40 (3.83%)
  • SKRN 595 10 (1.71%)
  • SLIS 5,150 -50 (-0.96%) © 2010 IMQ - LKBN ANTARA
  • SMAR 3,000 -100 (-3.23%)
  • SMBR 324 8 (2.53%)
  • SMCB 1,045 -20 (-1.88%)
  • SMDM 93 -6 (-6.06%)
  • SMDR 230 10 (4.55%)
  • SMGR 9,425 -75 (-0.79%)
  • SMKL-W 24 2 (9.09%)
  • SMMA 17,500 -500 (-2.78%)
  • SMMT 72 -1 (-1.37%)
  • SMRA 595 -20 (-3.25%)
  • SMSM 1,110 -15 (-1.33%)
  • SOCI 130 2 (1.56%)
  • SOFA 100 -11 (-9.91%)
  • SOFA-W 6 -1 (-14.29%)
  • SOSS 384 14 (3.78%)
  • SOTS 202 0 (0.00%)
  • SOTS-W 53 -1 (-1.85%)
  • SPMA 260 0 (0.00%)
  • SPTO 492 -2 (-0.40%)
  • SQMI 183 -2 (-1.08%)
  • SRAJ 127 -3 (-2.31%)
  • SRIL 194 -1 (-0.51%)
  • SRSN 58 0 (0.00%)
  • SRTG 2,710 10 (0.37%)
  • SSIA 382 -4 (-1.04%) © 2010 IMQ - LKBN ANTARA
  • SSMS 795 0 (0.00%)
  • STAR 133 8 (6.40%)
  • STTP 8,700 -50 (-0.57%)
  • SURE 2,930 0 (0.00%)
  • SWAT 95 2 (2.15%)
  • TAMA 154 -3 (-1.91%)
  • TAMA-W 5 -1 (-16.67%)
  • TAMU 60 -1 (-1.64%)
  • TAXI 50 0 (0.00%)
  • TBIG 1,125 10 (0.90%)
  • TBLA 580 -5 (-0.85%)
  • TBMS 670 -25 (-3.60%)
  • TCPI 3,740 -230 (-5.79%)
  • TDPM 93 0 (0.00%)
  • TEBE 1,405 -95 (-6.33%)
  • TECH 138 -10 (-6.76%)
  • TFAS 163 0 (0.00%)
  • TFCO 338 -20 (-5.59%)
  • TGRA 69 -1 (-1.43%)
  • TIFA 268 8 (3.08%)
  • TINS 625 -5 (-0.79%)
  • TKIM 7,075 -50 (-0.70%)
  • TLKM 3,110 0 (0.00%)
  • TMAS 105 -5 (-4.55%)
  • TMPO 148 2 (1.37%) © 2010 IMQ - LKBN ANTARA
  • TNCA 160 -11 (-6.43%)
  • TOBA 346 -2 (-0.57%)
  • TOPS 50 0 (0.00%)
  • TOTL 332 0 (0.00%)
  • TOTO 222 -2 (-0.89%)
  • TOWR 1,065 -5 (-0.47%)
  • TPIA 6,650 25 (0.38%)
  • TPMA 324 -4 (-1.22%)
  • TRIN 270 -2 (-0.74%)
  • TRIN-W 19 -2 (-9.52%)
  • TRIS 220 14 (6.80%)
  • TRUK 125 -6 (-4.58%)
  • TSPC 1,380 5 (0.36%)
  • TUGU 2,710 0 (0.00%)
  • TURI 1,400 0 (0.00%)
  • UANG 440 88 (25.00%)
  • UCID 1,450 0 (0.00%)
  • ULTJ 1,610 -10 (-0.62%)
  • UNIC 3,460 10 (0.29%)
  • UNIT 146 -4 (-2.67%)
  • UNSP 59 0 (0.00%)
  • UNTR 17,925 -525 (-2.85%)
  • UNVR 7,925 -50 (-0.63%)
  • URBN 1,555 0 (0.00%)
  • URBN-W 24 1 (4.35%) © 2010 IMQ - LKBN ANTARA
  • VICO 80 0 (0.00%)
  • VINS 123 2 (1.65%)
  • VINS-W 3 -1 (-25.00%)
  • VIVA 50 0 (0.00%)
  • VOKS 200 0 (0.00%)
  • WAPO 65 0 (0.00%)
  • WEGE 200 -2 (-0.99%)
  • WEHA 82 -3 (-3.53%)
  • WIIM 188 -10 (-5.05%)
  • WIKA 1,240 -30 (-2.36%)
  • WINS 93 2 (2.20%)
  • WOMF 204 0 (0.00%)
  • WOOD 396 -4 (-1.00%)
  • WOWS 50 -1 (-1.96%)
  • WSBP 202 0 (0.00%)
  • WSKT 715 -10 (-1.38%)
  • WTON 298 -2 (-0.67%)
  • XCID 87 0 (0.00%)
  • XCLQ 84 4 (5.00%)
  • XIHD 398 -4 (-1.00%)
  • XIIF 467 -7 (-1.48%)
  • XIIT 454 -2 (-0.44%)
  • XIJI 559 -11 (-1.93%)
  • XILV 99 -2 (-1.98%)
  • XIML 227 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • XIPI 142 -1 (-0.70%)
  • XISI 266 -2 (-0.75%)
  • XISR 329 -1 (-0.30%)
  • XNVE 113 0 (0.00%)
  • XPES 345 2 (0.58%)
  • XSBC 95 3 (3.26%)
  • XSSK 571 2 (0.35%)
  • YELO 50 0 (0.00%)
  • YELO-W 5 0 (0.00%)
  • YPAS 464 6 (1.31%)
  • ZBRA 50 -1 (-1.96%)
  • ZINC 142 0 (0.00%)
  • ZONE 416 2 (0.48%)
Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD
Published: 5 Nov 2019 14:21 WIB


IMQ, Jakarta —  Transaction further accelerates deleveraging

Strengthens alignment of Growth & Emerging Markets Business Unit portfolio with Takeda’s global business areas

OSAKA, Japan--(Antara/BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG (“STADA”), an international pharmaceutical company, for a total value of $660 million USD. The portfolio includes over-the-counter (OTC) and prescription pharmaceutical products exclusively in Russia, Georgia, and a number of countries from within the Commonwealth of Independent States, which form part of Takeda’s Growth & Emerging Markets Business Unit.

This is Takeda’s fourth divestment transaction in the past six months that contributes to the Company’s goal to divest approximately $10 billion USD in non-core assets to focus on its five key business areas and commitment to accelerating its deleveraging following its acquisition of Shire. Takeda completed the divestiture of Xiidra® to Novartis for up to $5.3 billion USD in July, announced the sale of TachoSil® to Ethicon for $400 million USD in May, and last month announced its sale of non-core assets in countries spanning Near East, Middle East and Africa to Acino for over $200 million USD.

“This announcement is the latest step in Takeda’s effort to simplify our portfolio, accelerate deleveraging, and continue to invest in our key business areas. We are making strong progress towards executing our strategy and delivering enhanced value for patients and Takeda shareholders,” said Costa Saroukos, Chief Financial Officer, Takeda.

The portfolio to be divested to STADA includes OTC Vitamins and Food Supplements, plus select products within the Cardiovascular, Diabetes, General Medicine, and Respiratory therapeutic areas. The portfolio’s growth is driven by sales of products such as Cardiomagnyl, and other strong regional brands. Combined, the portfolio of products to be divested to STADA and Acino generated revenues of approximately $300 million USD in fiscal year 2018.

While these trusted products continue to play important roles in meeting patient needs, they are not within Takeda's chosen business areas – Gastroenterology, Rare Diseases, Plasma-Derived Therapies, Oncology and Neuroscience – that are core to its global long-term growth.

“Takeda remains committed to the Emerging Markets, Russia and the countries included in this agreement. We will continue to increase patient access to our portfolio of highly innovative medicines across this region through our commercial activities and Access to Medicines program,” said Ricardo Marek, President, Growth & Emerging Markets Business Unit, Takeda. “As we execute on our divestiture goals, we continue to work to ensure that each transaction aligns with Takeda’s values. We are confident that STADA is well placed to provide patients with uninterrupted access to the divested products – a top priority for Takeda – and anticipate most of the employees supporting the divested assets will be given the opportunity to transition over to STADA once the divestiture is completed.”

Takeda intends to use the proceeds from this divestiture to continue to reduce its debt and accelerate deleveraging toward its target of 2.0x net debt/adjusted EBITDA over the next three to five years. Takeda is committed to rapid deleveraging driven by strong cash flow and divestiture proceeds, while also simplifying its portfolio.

Transaction Details

Takeda has entered into an agreement to sell a portfolio of approximately 20 select OTC and prescription pharmaceutical assets sold in Russia, Georgia and countries within the Commonwealth of Independent States namely: Armenia, Azerbaijan, Belarus, Kazakhstan, and Uzbekistan to STADA – an international pharmaceutical company with a two-pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer health products – for a total value of $660 million USD. Under the terms of the agreement, STADA will acquire the rights, title, and interest to the products in the portfolio exclusive to these countries.

It is anticipated that approximately 500 employees supporting the divested assets will be given the opportunity to transition over to STADA at closing. Further, Takeda and STADA will enter into manufacturing and supply agreements under which Takeda will continue to manufacture and supply the products to STADA.

The transaction is expected to close in Q4 FY19 (January- March 2020), subject to the satisfaction of customary closing conditions. Until then, the products will continue to be made avaliable to patients and manufactured and supplied by Takeda.

Takeda is being advised by BofA Securities (financial advisor) and White & Case (legal advisor) in this transaction.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

For more information, visit https://www.takeda.com

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. Forward-looking statements in this document are based on Takeda’s estimates and assumptions only as of the date hereof. Such forward-looking statements do not represent any guarantee by Takeda or its management of future performance and involve known and unknown risks, uncertainties and other factors, including but not limited to: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the timing and impact of post-merger integration efforts with acquired companies; and the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s), any of which may cause Takeda’s actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by such forward-looking statements. For more information on these and other factors which may affect Takeda’s results, performance, achievements, or financial position, see “Item 3. Key Information—D. Risk Factors” in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/reports/sec-filings/ or at www.sec.gov. Future results, performance, achievements or financial position of Takeda could differ materially from those expressed in or implied by the forward-looking statements. Persons receiving this press release should not rely unduly on any forward-looking statements. Takeda undertakes no obligation to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results of Takeda in this press release may not be indicative of, and are not an estimate, forecast or projection of Takeda’s future results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191104006136/en/

Contacts
Investor Relations:
Takashi Okubo
+81-(0)3-3278-2306
takeda.ir.contact@takeda.com

Media Inquiries:
Sandy Rodriguez
Head, Integration & Divestiture Communications
sandy.rodriguez@takeda.com

Vince Docherty
Head, Communications, GEM Business Unit
vince.docherty@Takeda.com

Kazumi Kobayashi (Japan)
+81 (0)3-3278-2095
kazumi.kobayashi@takeda.com

Source: Takeda Pharmaceutical Company Limited
Author: Business Wire
-
POPULAR NEWS